CA2326402A1 - Preparation of human papillomavirus e1 having helicase activity and method therefor - Google Patents

Preparation of human papillomavirus e1 having helicase activity and method therefor Download PDF

Info

Publication number
CA2326402A1
CA2326402A1 CA002326402A CA2326402A CA2326402A1 CA 2326402 A1 CA2326402 A1 CA 2326402A1 CA 002326402 A CA002326402 A CA 002326402A CA 2326402 A CA2326402 A CA 2326402A CA 2326402 A1 CA2326402 A1 CA 2326402A1
Authority
CA
Canada
Prior art keywords
leu
seq
ser
asp
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002326402A
Other languages
English (en)
French (fr)
Inventor
Alex Pelletier
Chris M. Farnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim (Canada) Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2326402A1 publication Critical patent/CA2326402A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002326402A 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor Abandoned CA2326402A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
US60/083,942 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (1)

Publication Number Publication Date
CA2326402A1 true CA2326402A1 (en) 1999-11-11

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326402A Abandoned CA2326402A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Country Status (9)

Country Link
US (1) US6306580B1 (cg-RX-API-DMAC7.html)
EP (1) EP1073750A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002513813A (cg-RX-API-DMAC7.html)
AU (1) AU767903B2 (cg-RX-API-DMAC7.html)
CA (1) CA2326402A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0101396A3 (cg-RX-API-DMAC7.html)
IL (1) IL139270A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ508519A (cg-RX-API-DMAC7.html)
WO (1) WO1999057283A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140524A0 (en) * 1998-07-21 2002-02-10 Boehringer Ingelheim Ca Ltd Regions of papilloma virus e1 helicase involved in e1 oligomerization
HUP0201512A3 (en) 1999-06-17 2010-01-28 Boehringer Ingelheim Ca Ltd New atpase assay
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
WO2003068940A2 (en) * 2002-02-14 2003-08-21 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) * 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Also Published As

Publication number Publication date
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
AU3592399A (en) 1999-11-23
AU767903B2 (en) 2003-11-27
US6306580B1 (en) 2001-10-23
JP2002513813A (ja) 2002-05-14
WO1999057283A1 (en) 1999-11-11
IL139270A0 (en) 2001-11-25
NZ508519A (en) 2003-12-19
HUP0101396A3 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
CN100535123C (zh) 蛋白酶检测系统
Hughes et al. E1 protein of human papillomavirus is a DNA helicase/ATPase
Vande Pol et al. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif
Andrés et al. African swine fever virus protease, a new viral member of the SUMO-1-specific protease family
US6825176B2 (en) E2 displacement assay for identifying inhibitors of HPV
AU767903B2 (en) Preparation of human papillomavirus E1 having helicase activity and method therefor
CA2439176A1 (en) Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
AU714821B2 (en) Methods, kits, and compositions for diagnosing papillomavirus infection
Yang et al. Biochemical characterization of Periplaneta fuliginosa densovirus non-structural protein NS1
Rocque et al. Replication-associated activities of purified human papillomavirus type 11 E1 helicase
Storey et al. Mutations in the human papillomavirus type 16 E2 protein identify a region of the protein involved in binding to E1 protein
US6916622B2 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA00010584A (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
US6518014B1 (en) Hepadnavirus cores
US6322792B1 (en) Rhadino virus LANA acts in trans on a unit of rhadino virus DNA to mediate efficient episome persistance
EP0938555B1 (en) Constructs and complexes of cyclin e
AU2004200590A1 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA01000693A (en) Regions of papilloma virus e1 helicase involved in e1 oligomerization
GB2311069A (en) Primase isolated from human cytomegalovirus (HCMV)
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
WO1999057536A2 (en) Cyclin activation kinase (cak) from human pathogens, and uses related thereto
Taylor The role of DNA damage proteins and signaling pathways in the regulatory functions of the Human Papillomavirus 16 E2 protein
KR19990086165A (ko) Cdk4 의 저해제인 p16의 카복시말단이 절단된 결손형cδp16 단백질, 그의 유전자

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued